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813 ± 43
769 ± 14
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111 ± 36
159 ± 57*
LF15 HF15
NE uptake
133 ± 9
49 ± 11'
64 ± 8'
40 ± g,t
91 ± 28
189 ± 63
Baseline
LF10 HF10
Supine
CCF 19 ± 8 63 ± 9' 18 ± 5 54 ± 7 13±4 47 ± 8' 16± 6 49± 8
Normal 14 ± 6 68 ± 8 18 ± 6 58 ± 10 15± 6 70± 5 22 ± 9 55 ± 10
Stand
CCF 15 ± 7 66 ± 6 19 ± 7 46± 8 30± 10 51 ± 9 7 ± 5 31 ± 10
Normal 28 ± 9 55 ± 8 30 ± 9 42± 9 58± 10 27 ± 5 50 ± 12 17 ± 5
;514 mmHg
>14mmHg
Conclusion: This study demonstrates that the acute administration of
digoxin reduces cardiac NESP in patients with CHF and high LV filling pres-
sures. This reduction in cardiac sympathetic activity appears to be mediated
by a non-hemodynamic mechanism, since digoxin in the dose used in this
study did not cause changes in either the loading conditions or the contrac-
tile state of the LV
Values are mean ± SE. 'p < 005 vs. SHAM; t P < 0.05 vs. CHF
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Desipramine Attenuates the Cardiac Sympathetic
Nerve Terminal Abnormalities in Congestive Heart
Failure
Akita Yatani, Suzanne Y. Felten, Yoshihiro Himura, Michihiro Kashiki,
Chang-seng Liang University of Rochester Med. Ctr., Rochester, NY
All data expressed as mean ± SEM.·p ~ 0.016, by paired t test
We have shown that cardiac norepinephrine (NE) reuptake activity and tyro-
sine hydroxylase (TH), a rate-limiting enzyme for NE synthesis, are reduced in
congestive heart failure (CHF). To determine whether the changes of TH are
caused by neurotoxic effects of NE, we administered the neuronal uptake
inhibitor desipramine (OMI, 225 mg/day) to pacing-induced CHF and sham-
operated (SHAM) dogs for 6 weeks. CHF was characterized by tachycardia,
low aortic pressure, elevated left atrial pressure, decreased left ventricular
dP/dt and reduced cardiac output. OMI produced no hemodynamic effects.
The effects of OMI on left ventricular NE uptake activity (fmollmgl15 min)
and immunocytochemical TH profiles were:
LVEDP Cardiac NESP (pmollmin)
Results: LF & HF spectral power in normalized units (%); S ~ spontaneous
(mean ± SEM)
The effect of cardiac glycosides on cardiac sympathetic activity in congestive
heart failure (CHF) remains uncertain.
Methods: We measured total body and cardiac norepinephrine spillover
(NESP) using the norepinephrine isotope-dilution technique at baseline and
30 minutes after digoxin (0.25 mg iv). LV pressure, its first derivative (Millar),
and systemic BP were also measured before and after digoxin. We studied
15 patients with CHF; 5 with normal LV filling pressures (LVEOP :s 14, mean
9 ± 2 mmHg). and 10 with high LV filling pressures (LVEOP > 14. mean 26
±3 mmHg).
Results: The groups had similar baseline HR, BP. and LV +dP/dt. The high
LVEOP group had a lower EF (20 ± 2 vs 34 ± 2%, p < 0.05), a lower CI (1.7 ±
0.2 vs 2.8 ± 0.3 Llmin/m2 , p < 0.05), and higher mean PA pressures (31 ±4vs
14± 2 mmHg, p < 0.05} at baseline, as compared to the normal LVEOP group.
HR, BP. LVEOP, LV +dp/dt, coronary sinus blood flow, and total body NESP did
not change in either group following digoxin. Cardiac NESP was unchanged
in response to digoxin in the normal LVEOP group. Importantly, digoxin
caused a consistent reduction in cardiac NESP in the high LVEOP group:
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Effect of Digoxin on Cardiac Sympathetic Activity in
Congestive Heart Failure
Gary E. Newton, Jeffrey H. Tong, Anne M. Schofield, Andrew D. Baines, John
S. Floras, John D. Parker Mount Sinai Hospital, Toronto, Canada
'p < 0.05
Supine HF power falls with increasing respiratory rate in most CCF pts
and this effect is similar to that seen in normals on standing (I.e. at increased
sympathetic levels). An improvement in clinical state of CCF pts will lower
respiratory rate and this effect alone will increase HF power rather than any
therapy.
Group
SHAM In ~ 12)
SHAM + OMI (n = 6)
CHF In ~ 12)
CHF + OMI (n = 7)
Mean EG as %CLEGMin R-CMax R-B
104 ± 31 ms 124 ± 35 ms 29-49 ms 22-31 %
97 ± 21 ms 101 ± 25 ms 30-35 ms 23-30%
p = 0.28 p = 0.008
Group Mean R-C
5 Day 154 ± 29 ms
BWeek 132 ± 23 ms
p = 0.002
5.5 msec. The incidence of reentry was 0.018 ± 0.048 rotations/sec-em2. Of
the 18 runs of VF in dogs with ablated ventricles, 8 episodes of reentry were
detected. The mean lifespan was 3.6 ± 1.1 rotations (p = 0.39 compared
with intact ventricles). The mean cycle length was 107.2 ± 9.6 msec (p =
0.16). The incidence of reentry was 0.075 ± 0.097 rotations/sec-cm2 (p =
0.048). In both groups of dogs, dynamic displays of the activation patterns
demonstrate that the reentrant wavefronts spiral rather than follow a sim-
ple circular pathway. Conclusions: (a) reentrant wavefronts are consistently
present during Wiggers' stage II VF, (b) ablation of the subendocardium and
Purkinje fibers results in an increased incidence of reentrant wavefronts on
the epicardium, and (c) the reentrant wavefronts are compatible with spiral
waves of excitation.
The mean R-C at these sites was longer than the mean VFCL for all sites in
the 5 day group (mean VFCL 133 ± 22 ms at 5 days, 130 ± 15 ms at 8 weeks).
A trend toward a longer upper limit of EG was seen in the 5 day group (p =
0.08). In 29% of all sites (36% at 5 days, 20% at 8 weeks) a significant EG
(2:10 ms) was not present.
Conclusions: An excitable gap exists at most sites during VF in a canine
model of myocardial infarction, but is absent in a minority of sites. The gap
may be shorter in absolute duration in chronic infarction (8 weeks) than in
subacute infarction (5 days). although the proportion of cycle length occu-
pied by the EG is similar in both groups. The site to site heterogeneity in the
magnitude and presence of EG in infarcted myocardium has implications for
the use of pacing techniques to modulate VE
[808-41 The Presence and Duration of an Excitable Gap
During Ventricular Fibrillation in a Canine Model of
Myocardial Infarction
George Horvath, Nikhil Patel, Roger S. Damle, Sandeep Jam, Nikki S. Robinson,
Jeffrey J. Goldberger, Alan H. Kadish. Northwestern University Medical School,
Chicago,lL
An excitable gap (EG) occupying 50% of the cycle length has been reported
in a non-infarcted canine model of ventricular fibrillation (VF). To evaluate the
presence and duration of an EG in VF post infarction, we studied 9 mongrel
dogs at 5 days (n = 5) and 8 weeks (n = 4) post LAO ligation. VF induced
by programmed stimulation was recorded using an 8 by 14 electrode array
(2.5 mm interelectrode distance) over the infarcted area. The mean VF cycle
length (VFCL) was determined at each site. EG was determined by a wave-
front analysis propagation method. Sites at which both conduction and block
occurred on different cycles were analyzed. At each, the interval from each
activation to the subsequent blocked (R-B) or conducted (R-C) impulse was
recorded, along with the R-C interval immediately preceding. The recovery
period at each site was estimated as the range bounded by the maximal R-B
and minimal R-C. The EG was determined by the difference of the recovery
period and the mean R-C at each site. Results: Fifty eight sites were suitable
for analysis.
Results of analysis (Mean or mean ± standard deviation):
Power spectral analysis of heart rate variability is frequently used as an easy
non invasive method for assessing autonomic tone. However changes in res-
piratory rate are frequently ignored and these may have an important effect
on the measurements of spectral components, especially in heart failure. We
have assessed the effect of different respiratory rates (10, 15, 20 min-1 and
spontaneous) on low frequency (LF) and high frequency (HF) components
of HR variability in 11 heart failure pts (CCF) (EF ~ 40 ± 4%; 9 males) and 9
normal subjects (5 males).
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Different Respiratory Rates Affect the Measurement
of Autonomic Tone by Power Spectral Analysis of
Heart Rate Variability In Patients with Heart Failure
John E. Sanderson, Dickens T.K. Yeung, Leata Y.C. Yeung, Richard L.G. Kay,
8rian Tomlinson, Luciano Bernardi 1, Kam S. Woo. Chinese University ofHong Kong:
1 University of Pavia, Italy
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